CatalystMacro

LEGEND BIOTECH SHARES RISE 5 % AS Q2 EARNINGS AND REVENUE BEAT ESTIMATES

Q2 earnings and revenue beat estimates, lifting shares 5%.

What changed

Q2 earnings and revenue beat estimates, lifting shares 5%.

Why it matters

Q2 earnings and revenue beat estimates, lifting shares 5%. — impact context not separately stored; see What changed.

Sources